NATRECOR Drug Patent Profile
✉ Email this page to a colleague
When do Natrecor patents expire, and what generic alternatives are available?
Natrecor is a drug marketed by Scios Llc and is included in one NDA.
The generic ingredient in NATRECOR is nesiritide. There are two drug master file entries for this compound. Additional details are available on the nesiritide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NATRECOR?
- What are the global sales for NATRECOR?
- What is Average Wholesale Price for NATRECOR?
Summary for NATRECOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 33 |
Drug Prices: | Drug price information for NATRECOR |
DailyMed Link: | NATRECOR at DailyMed |
Recent Clinical Trials for NATRECOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Virginia Commonwealth University | Phase 4 |
John C Burnett | Phase 1/Phase 2 |
Mayo Clinic | Phase 1/Phase 2 |
US Patents and Regulatory Information for NATRECOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NATRECOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Scios Llc | NATRECOR | nesiritide | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NATRECOR
See the table below for patents covering NATRECOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2511160 | ⤷ Sign Up | |
Germany | 68923878 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 8912069 | ⤷ Sign Up | |
Ireland | 68889 | Recombinant techniques for production of novel natriuretic and vasodilator peptides | ⤷ Sign Up |
European Patent Office | 0418308 | TECHNIQUES RECOMBINANTES DE PRODUCTION DE NOUVEAUX PEPTIDES NATRIURETIQUES ET VASODILATATEURS. (RECOMBINANT TECHNIQUES FOR PRODUCTION OF NOVEL NATRIURETIC AND VASODILATOR PEPTIDES.) | ⤷ Sign Up |
Australia | 3768189 | ⤷ Sign Up | |
Japan | H03505280 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |